MarketPulse

clinical study

3 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Alpha Tau Completes Pivotal Study for Skin Cancer Treatment, Targeting FDA Approval

Alpha Tau Medical completes enrollment of 88 patients in pivotal skin cancer trial, advancing toward FDA approval of Alpha DaRT® for recurrent squamous cell carcinoma.
DRTSDRTSWFDA approvalclinical study
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Precipio Posts 30% Revenue Growth; Partners with Memorial Sloan-Kettering on Cancer Test

Cancer diagnostics firm $PRPO reports $24M in 2025 revenues, up 30% year-over-year, and publishes peer-reviewed study on its BCR::ABL1 blood test.
PRPOQ4 2025 earningsrevenue growth
BenzingaBenzinga··Prnewswire

IceCure's Cryoablation Wins Independent Validation for Breast Fibroadenomas

IceCure's ProSense cryoablation achieved 92.9% volume reduction in independent breast fibroadenoma study, validating technology for a 63,000-patient annual U.S. market.
ICCMmedical deviceminimally invasive surgery